Guidelines and Codes
Update to Section 12.10.6 Corticosteroids as aqueous solutions for nasal inhalation [NZRGM, Volume 1, 5th edition]
Added to web site: July 2006
Low dose beclomethasone, budesonide, fluticasone and mometasone aqueous nasal preparations may be sold as Pharmacy Medicines for use in the short-term prophylaxis and treatment of allergic rhinitis when the following conditions apply:
| Type of preparation | Non CFC aqueous formulations |
|---|---|
| Strength | Beclomethasone NMT 50mcg/actuation Budesonide NMT 50 mcg/actuation Fluticasone NMT 50 mcg/actuation Mometasone NMT 50 mcg/actuation |
| Pack size | Not more than 200 doses |
| Indications | Short term (3-6 months) prophylaxis or treatment of allergic rhinitis (hay fever) in adults and children aged 12 years and over |
| Dosage | Beclomethasone & Budesonide Maximum of 400mcg (200mcg/nostril) per day in divided doses Fluticasone & Mometasone Maximum daily dose of 200 mcg as a single dose |
| Use1 | Do not exceed maximum stated dose Dose should be reduced for maintenance treatment once full effect obtained Do not use for more than 6 months without the advice of your doctor or pharmacist. |
| Warning Statements1 | See your doctor or pharmacist before using this product if:
See your doctor or pharmacist before using this product if:
See your doctor or pharmacist if:
|
| Contraindications | As per data sheet |
| Adverse Effects | As per data sheet |
| Additional Warnings and Precautions | As per data sheet |
1This information may be presented as words of similar meaning, and
may be present on either the label or the package insert. Where the
information is included in the package insert, the label should include a
statement such as:
Read the enclosed package insert before starting to use this product
